LightForce Hires New Chief Financial Officer, Gene Fetisov

BURLINGTON, MA. (Sept. 2023) - In an exciting development, LightForce, the innovative creators of the world’s first fully personalized 3D printed braces, proudly introduces its latest addition, Gene Fetisov, as Chief Financial Officer. Gene, the former Chief Financial Officer of Semrush ($SEMR), steps into this pivotal role as LightForce gears up for growth following the announcement of Series D funding.

Gene Fetisov brings over 25 years of financial leadership expertise to LightForce. He has an impressive track record of not only nurturing the growth of companies but also steering them towards successful IPOs. His appointment is a strategic move that reaffirms LightForce’s commitment to taking the dental technology industry to new heights.

“Gene has been a very successful CFO for several high-growth companies in large markets where technology was the key leverage,” said LightForce CEO and Co-Founder, Dr. Alfred Griffin, DMD, PhD, MMSc. Dr. Griffin continues to highlight the significance of Gene’s appointment, stating, “He has a history of growing companies and taking them public when it serves the business. Gene’s financial experience and ability to solve complex problems quickly will be invaluable to the LightForce team as we continue to expand in the market and support orthodontists who embrace digital orthodontics.”

The arrival of Gene Fetisov coincides with an exciting phase of development for LightForce. Their pioneering work in creating fully personalized 3D printed braces is helping to shape the future of orthodontics. With Gene's financial expertise and strategic vision, LightForce is poised to scale its manufacturing capabilities and extend its support to a broader spectrum of customers across the market.

"I am truly impressed by the work that LightForce has done," expresses Gene Fetisov. "They have built an impressive company that will continue to grow into the large global dental market, transforming it with personalized product and digital treatment planning. With this latest round of funding, we will be able to focus on scaling our manufacturing and go-to-market functions reaching out to a larger number of customers."

The Series D funding announcement and Gene Fetisov's appointment are part of a new wave of growth and innovation for LightForce. LightForce will continue to make waves in the industry, embracing growth as a means to create a brighter, more confident smile for people around the world.

Return to the blog